ALLO
Price
$2.89
Change
+$0.03 (+1.05%)
Updated
Apr 26, 6:59 PM EST
4 days until earnings call
KOD
Price
$3.28
Change
+$0.10 (+3.14%)
Updated
Apr 26, 6:59 PM EST
16 days until earnings call
Ad is loading...

Compare trend and price ALLO vs KOD

Header iconALLO vs KOD Comparison
Open Charts ALLO vs KODBanner chart's image
Allogene Therapeutics
Price$2.89
Change+$0.03 (+1.05%)
Volume$1.6M
CapitalizationN/A
Kodiak Sciences
Price$3.28
Change+$0.10 (+3.14%)
Volume$154.37K
CapitalizationN/A
View a ticker or compare two or three
ALLO vs KOD Comparison Chart

Loading...

ALLODaily Signal changed days agoGain/Loss if shorted
 
Show more...
KODDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALLO vs. KOD commentary
Apr 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a StrongSell and KOD is a StrongSell.

COMPARISON
Comparison
Apr 27, 2024
Stock price -- (ALLO: $2.89 vs. KOD: $3.28)
Brand notoriety: ALLO and KOD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 109% vs. KOD: 30%
Market capitalization -- ALLO: $493.39M vs. KOD: $172.31M
ALLO [@Biotechnology] is valued at $493.39M. KOD’s [@Biotechnology] market capitalization is $172.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $556.22B to $0. The average market capitalization across the [@Biotechnology] industry is $2.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileKOD’s FA Score has 1 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • KOD’s FA Score: 1 green, 4 red.
According to our system of comparison, KOD is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 4 TA indicator(s) are bullish while KOD’s TA Score has 4 bullish TA indicator(s).

  • ALLO’s TA Score: 4 bullish, 4 bearish.
  • KOD’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ALLO is a better buy in the short-term than KOD.

Price Growth

ALLO (@Biotechnology) experienced а -16.71% price change this week, while KOD (@Biotechnology) price change was -2.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.69%. For the same industry, the average monthly price growth was -8.16%, and the average quarterly price growth was +1262.42%.

Reported Earning Dates

ALLO is expected to report earnings on Aug 07, 2024.

KOD is expected to report earnings on Aug 12, 2024.

Industries' Descriptions

@Biotechnology (+1.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALLO with price predictions.
OPEN
A.I.dvisor published
a Summary for KOD with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ALLO($493M) has a higher market cap than KOD($172M). KOD YTD gains are higher at: 7.895 vs. ALLO (-9.969).
ALLOKODALLO / KOD
Capitalization493M172M287%
EBITDAN/AN/A-
Gain YTD-9.9697.895-126%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
ALLOKOD
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend about 1 month ago
81%
Bullish Trend 18 days ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
ALLODaily Signal changed days agoGain/Loss if shorted
 
Show more...
KODDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ADCIX26.490.48
+1.85%
American Century Disciplined Growth I
SROIX11.530.16
+1.41%
Calamos Antetokounmpo Sustainable Eqs I
OPOCX91.210.56
+0.62%
Invesco Discovery A
CRRYX17.790.11
+0.62%
Columbia Small Cap Value II Inst3
JVSCX14.760.09
+0.61%
Janus Henderson Small-Mid Cap Value C

ALLO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with NTLA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLO
1D Price
Change %
ALLO100%
+1.23%
NTLA - ALLO
61%
Loosely correlated
+3.70%
BEAM - ALLO
55%
Loosely correlated
-1.02%
DNLI - ALLO
50%
Loosely correlated
+3.14%
CTMX - ALLO
48%
Loosely correlated
-0.62%
EDIT - ALLO
48%
Loosely correlated
+1.92%
More

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with NTLA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
+2.98%
NTLA - KOD
40%
Loosely correlated
+3.70%
STOK - KOD
40%
Loosely correlated
+6.16%
NUVB - KOD
40%
Loosely correlated
+2.29%
INZY - KOD
37%
Loosely correlated
+2.54%
CMPX - KOD
36%
Loosely correlated
-2.03%
More